1. [O5–03–03]: LEVERAGING MEDICARE CLAIMS TO CHARACTERIZE DIAGNOSTIC PATHWAYS IN ALZHEIMER's DISEASE. (1st July 2017) Authors: Khandker, Rezaul Karim; Mehta, Vinay; Black, Christopher M.; Voss, Tiffini; Dubin, Brady; Ambegaonkar, Baishali M.; Marsico, Mark Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 30 Page Start: P1459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine. (August 2016) Authors: Voss, Tiffini; Lipton, Richard B; Dodick, David W; Dupre, Nicole; Ge, Joy Yang; Bachman, Robert; Assaid, Christopher; Aurora, Sheena K; Michelson, David Journal: Cephalalgia Issue: Volume 36:Number 9(2016) Page Start: 887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease. Issue 11 (13th October 2020) Authors: Wessels, Alette M.; Lines, Christopher; Stern, Robert A.; Kost, James; Voss, Tiffini; Mozley, Lyn Harper; Furtek, Christine; Mukai, Yuki; Aisen, Paul S.; Cummings, Jeffrey L.; Tariot, Pierre N.; Vellas, Bruno; Dupre, Nicole; Randolph, Christopher; Michelson, David; Andersen, Scott W.; Shering, Cr... Journal: Alzheimer's & dementia Issue: Volume 16:Issue 11(2020) Page Start: 1483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FTS3‐01‐05: FURTHER ANALYSES OF COGNITIVE OUTCOMES IN THE APECS PHASE‐3 TRIAL OF VERUBECESTAT IN PRODROMAL AD. (1st July 2019) Authors: Egan, Michael F.; Kost, James; Lines, Christopher; Voss, Tiffini; Mozley, Lyn Harper; Furtek, Christine; Mukai, Yuki; Aisen, Paul S.; Cummings, Jeffrey L.; Tariot, Pierre N.; Vellas, Bruno; Dupre, Nicole; Randolph, Christopher; Sur, Cyrille; Michelson, David Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 17 Page Start: P874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Making Better Dose Decisions: Using Exposure‐Response Modeling to Integrate Efficacy Outcome of Two Phase IIb Clinical Trials of Ubrogepant for Migraine Treatment. Issue 3 (16th January 2020) Authors: Li, Chi‐Chung; Voss, Tiffini; Kowalski, Ken; Yang, Bei; Kleijn, Huub Jan; Jones, Christopher J.; Bosch, Rolien; Michelson, David; DeAngelis, Matthew; Xu, Yang; Xie, Iris; Kothare, Prajakti A. Journal: Clinical and translational science Issue: Volume 13:Issue 3(2020) Page Start: 482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. O3‐10‐02: VERUBECESTAT‐INDUCED BRAIN VOLUME LOSS OCCURS RAPIDLY AND ONLY IN AMYLOID‐ENRICHED BRAIN REGIONS IN EPOCH, A PHASE 3 TRIAL IN MILD‐TO‐MODERATE ALZHEIMER'S DISEASE PATIENTS. (1st July 2019) Authors: Sur, Cyrille; Kost, James; Scott, David; Adamczuk, Katarzyna; Fox, Nick C.; Cummings, Jeffrey L.; Tariot, Pierre N.; Aisen, Paul S.; Vellas, Bruno; Voss, Tiffini; Mukai, Yuki; Michelson, David; Egan, Michael F. Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 17 Page Start: P909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1‐038: VERUBECESTAT PHARMACOKINETIC AND EXPOSURE‐RESPONSE RESULTS FROM EPOCH: A PHASE 3 TRIAL IN MILD‐TO‐MODERATE ALZHEIMER'S DISEASE. (1st July 2006) Authors: Stone, Julie A.; Kleijn, Huub Jan; Jaworowicz, David J.; Dockendorf, Marissa; Xu, Ming; Rasmussen, Christian; Humphrey, Rebecca; Voss, Tiffini; Egan, Mike F. Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 5 Page Start: P281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P1‐042: NEUROFIBRILLARY TANGLE IMAGING WITH [18F]MK‐6240 IN APECS, A PHASE 3 TRIAL IN PRODROMAL ALZHEIMER'S DISEASE PATIENTS. (1st July 2019) Authors: Sur, Cyrille; Lohith, Talakad G.; Taylor, Theresa; Dupre, Nicole; Furtek, Christine; Kost, James; Scott, David; Adamczuk, Katarzyna; Voss, Tiffini; Egan, Michael F. Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 4 Page Start: P249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1‐044: VERUBECESTAT DISEASE PROGRESSION MODELING FROM APECS, A PHASE 3 TRIAL IN PRODROMAL ALZHEIMER'S DISEASE: NO DOSE‐ AND EXPOSURE‐DEPENDENCY IN CLINICAL ENDPOINTS. (1st July 2019) Authors: Stone, Julie A.; Kleijn, Huub Jan; Xu, Ming; Kost, James; Furtek, Christine; Mukai, Yuki; Dupre, Nicole; Voss, Tiffini; Egan, Michael F. Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 4 Page Start: P249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P2‐014: Relationship Between Volumetric MRI Parameters, APOE4 and MMSE Status at Baseline in The Verubecestat (MK‐8931) Mild to Moderate Alzheimer's Disease Phase 2/3 Trial. (1st July 2016) Authors: Sur, Cyrille; Mo, Yi; Kost, James; Voss, Tiffini; Suhy, Joyce; Bracoud, Luc; Oh, Joonmi; Michelson, David; Egan, Michael Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 12 Page Start: P613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗